Claris Advisors’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-32
Closed -$3.2K 662
2024
Q3
$3.2K Buy
+32
New +$3.2K ﹤0.01% 304